ASB vs HLNE

ASB presents a strong value opportunity, characterized by a stable Piotroski F-Score of 4/9 and a current price ($27.85) trading significantly below its Graham Number ($42.68) and book value (P/B 0.95). While the technical trend is currently bearish (10/100), the fundamental profile is supported by a consistent track record of earnings beats over 25 quarters and a sustainable dividend payout. The massive YoY revenue growth suggests inorganic expansion, which, combined with a low P/E of 10.05, indicates the market is underpricing the company's assets and earnings power.

HLNE exhibits exceptional fundamental health with a Piotroski F-Score of 8/9 and a very low Debt/Equity ratio of 0.28. While the current price of $92.28 trades at a premium to its Graham Number ($49.52) and Intrinsic Value ($71.80), it remains significantly undervalued relative to its analyst target of $155.14 and sector average P/E. The stock is currently experiencing a severe technical correction, trading near its 52-week low, which creates a compelling entry point for a company with 31.7% ROE and consistent earnings beats. The divergence between deteriorating price action and strengthening financial health suggests a high-probability reversal.